The effect of circulating androgens on bone mineral density in postmenopausal women

Maturitas

Volumn 48, Issue 3, 2004, Pages 235-242

  Tok, Ekrem C ^a   Ertunc, Devrim ^b   Oz, Utku ^a   Camdeviren, Handan ^a   Ozdemir, Gulay ^a   Dilek, Saffet ^c  

^a MERSIN UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

^c Zekai Tahir Burak Women Hospital   (Turkey)

Author keywords

Bone mineral density; Endogenous androgens; Postmenopausal women

Indexed keywords

ANDROGEN; ANDROSTENEDIOL; PRASTERONE SULFATE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HORMONAL THERAPY; HUMAN; LINEAR REGRESSION ANALYSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; TESTOSTERONE BLOOD LEVEL; TRABECULAR BONE;

ADULT; AGED; ANDROGENS; ANDROSTENEDIONE; BONE DENSITY; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; TESTOSTERONE;

EID: 2942716746     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.11.007     Document Type: Article

References (35)

1. Lindsay R. The menopause and osteoporosis. Obstet. Gynecol. 87:1996;16S-19S
2. Riffee J.M. Osteoporosis: prevention and management. Ann. Pharm. 32:1992;665-676
3. Ettinger B. Optimal use of postmenopausal hormone replacement. Obstet. Gynecol. 72:1988;31S-36S
4. Johansson C., Mellstrom D., Milsom I. Reproductive factors as predictors of bone density and fractures in women at the age of 70. 17:1993;39-50
5. Raisz L.G., Wiita B., Artis A., Bowen A., Schwartz S., Trahiotis M., et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J. Clin. Endocrinol. Metab. 81:1996;37-43
6. Davis S.R., McCloud P., Strauss B.J., Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 21:1995;227-236
7. Greendale G.A., Edelstein S., Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J. Bone Miner. Res. 12:1997;1833-1843
8. Longcope C., Baker R.S., Hui S.L., Johnston C.C. Jr. Androgen and estrogen dynamics in women with vertebral crush. Maturitas. 6:1984;309-318
9. Savvas M., Studd J.W., Norman S., Leather A.T., Garnett T.J., Fogelman I. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in postmenopausal women who have previously received long-term oral estrogens. Br. J. Obstet. Gynaecol. 99:1992;757-760
10. Watts N.B., Notelovitz M., Timmons M.C., Addison W.A., Wiita B., Downey L.J. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet. Gynecol. 85:1995;529-537
11. Labrie F., Diamond P., Cusan L., Gomez J.L., Belanger A., Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J. Clin. Endocrinol. Metab. 82:1997;3498-3505
12. Abraham G.E. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J. Clin. Endocrinol. Metab. 39:1974;340
13. Burger H.G., Dudley E.C., Hopper J.L., Shelley J.M., Green A., Smith A., et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J. Clin. Endocrinol. Metab. 80:1995;3537-3545
14. Roger M., Nahoul K., Scholler R., Bagrel D. Evolution with ageing of four plasma androgens in postmenopausal women. Maturitas. 2:1980;171-177
15. Colvard D.S., Eriksen E.F., Keeting P.E., Wilson E.M., Lubahn D.B., French F.S., et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc. Natl. Acad. Sci. USA. 86:1989;854-857
16. Abu E.O., Horner A., Kusec V., Triffitt J.T., Compston J.E. The localization of androgen receptors in human bone. J. Clin. Endocrinol. Metab. 82:1997;3493-3497
17. Kasperk C., Helmboldt A., Borcsok I., Heuthe S., Cloos O., Niethard F., et al. Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations. Calcif. Tissue Int. 61:1997;464-473
18. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78:1994;1360-1367
19. Arlt W., Haas J., Callies F., Reincke M., Hubler D., Oettel M., et al. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J. Clin. Endocrinol. Metab. 84:1999;2170-2176
20. Labrie F., Luu-The V., Labrie C., Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front. Neuroendocrinol. 22:2001;185-212
21. Douchi T., Oki T., Yamasaki H., Kuwahata R., Nakae M., Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet. Gynecol. 98:2001;445-449
22. Adami S., Zamberlan N., Castello R., Tosi F., Gatti D., Moghetti P. Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clin. Endocrinol. (Oxf). 48:1998;169-173
23. Miller K.K., Biller B.M., Hier J., Arena E., Klibanski A. Androgens and bone density in women with hypopituitarism. J. Clin. Endocrinol. Metab. 87:2002;2770-2776
24. Khosla S., Melton L.J. III, Atkinson E.J., O'Fallon W.M., Klee G.G., Riggs B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J. Clin. Endocrinol. Metab. 83:1998;2266-2274
25. Wu F., Ames R., Clearwater J., Evans M.C., Gamble G., Reid I.R. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin. Endocrinol. (Oxf). 56:2002;703-711
26. Nawata H., Tanaka S., Tanaka S., Takayanagi R., Sakai Y., Yanase T., et al. Aromatase in bone cell: association with osteoporosis in postmenopausal women. J. Steroid. Biochem. Mol. Biol. 53(1-6):1995;165-174
27. Rozenberg S., Ham H., Bosson D., Peretz A., Robyn C. Age. Maturitas. 12:1990;137-143
28. Orozco P., Navarro M.A., Nolla J.M. Salivary testosterone is associated with higher lumbar bone mass in premenopausal healthy women with normal levels of serum testosterone. Eur. J. Epidemiol. 16:2000;907-912
29. Szathmari M., Szucs J., Feher T., Hollo I. Dehydroepiandrosterone sulphate and bone mineral density. Osteoporos. Int. 4:1994;84-88
30. Haden S.T., Glowacki J., Hurwitz S., Rosen C., LeBoff M.S. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women. Calcif. Tissue Int. 6(6):2000;414-418
31. Jassal S.K., Barrett-Connor E., Edelstein S.L. Low bioavailable testosterone levels predict future height loss in postmenopausal women. J. Bone Miner. Res. 10(4):1995;650-654
32. Marcus R., Leary D., Schneider D.L., Shane E., Favus M., Quigley C.A. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 85:2000;1032-1037
33. Schwartz BD, Zhu YS, Cordero J, Imperato-McGinley J. 5α-Reductase deficiency and complete androgen insensitivity: natural models to suggest a direct role for androgens on bone density in men. In: Proceedings of the 81st Annual Meet of the Endocrine Society, 1999 [Abstract OR23-1].
34. Villareal D.T., Holloszy J.O., Kohrt W.M. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin. Endocrinol. (Oxf). 53:2000;561-568
35. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids. Clin. Endocrinol. (Oxf). 49:1998;421-432